SDGR Schrodinger, Inc.

$19.02▲ +1.17% Healthcare Other
After hours $19.01▼ -0.05% Sep 11, 7:33 PM ET
Volume 464.1K Avg Volume (10D) 919.8K
Key Metrics & Fundamentals
Market Cap
$1.42B
P/E Ratio
–
Div Yield
–%
52W Range
10.95 - 23.02
% vs 50 MA
8.33%
% vs 200 MA
25.51%
RSI-14
50.8
MACD Histogram
-0.2500
Beta (1Y vs SPY)
1.61
Free Cash Flow
-$34.43M
Gross Rev
$58.89M
Gross Profit
$32.43M
EBITDA
-$85.93M
COGS
$26.46M
Operating Exp
$73.98M
Operating Income
-$41.55M
EBIT
-$41.55M
Pretax Income
$7.35M
Net Income
$5.98M
EPS (Diluted)
0.08
Price & Volume History
Loading chart…
Recent News
Schrodinger Establishes Tectora Therapeutics With RA Capital, New Enterprise Associates
MT Newswires · Sep 9, 2026 11:33 AM
Schrödinger Announces Licensing and Collaboration Agreement with Tectora Therapeutics, a New Biotechnology Company It Co-founded to Advance Immunology and Inflammation Programs
Business Wire · Sep 9, 2026 11:00 AM
Can RXRX's Pipeline Expansion Strengthen Its Long-Term Growth Outlook?
Zacks · Sep 3, 2026 2:32 PM
AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030
CNW Group · Sep 3, 2026 12:55 PM
Schrödinger to Present at Morgan Stanley Global Healthcare Conference
Business Wire · Sep 1, 2026 12:30 PM
The Zacks Analyst Blog Highlights Recursion Pharmaceuticals, Schrodinger, Relay Therapeutics and Absci
Zacks · Aug 18, 2026 7:43 AM
4 AI-Powered Drug Discovery Stocks to Watch as AI Reshapes Pharma
Zacks · Aug 17, 2026 1:56 PM
UBS Adjusts Schrodinger PT to $19 From $13, Maintains Neutral Rating
MT Newswires · Aug 14, 2026 1:38 PM
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Business Wire · Aug 14, 2026 12:30 PM
The Biggest IPO of the Year Is Targeted in the Next 60 Days. Why One Unexpected Industry Could Rally Before Then (Hint: It’s Not Tech)
24/7 Wall St. · Aug 11, 2026 6:00 PM
Financial Overview - Income Statement Quarterly

See SDGR's money flow as a full page

Social Sentiment
Avg +0.84 · 6 posts
DDTradeI’m back all in
r/wallstreetbets · May 28, 2026
The author views SDGR favorably due to its industry position and technological advancements.
positive +0.60
TradeDiscussionDDPharma AI - might still be too early
r/wallstreetbets · May 4, 2026
The author presents SDGR as a leading company in embedded software AI across pharma, generating real revenue.
positive +0.70
NewsTradeDDBlackRock buying 12,7% SDGR
r/wallstreetbets · Jul 18, 2025
BlackRock's investment is a positive signal for SDGR, indicating increased institutional interest.
very_positive +1.00
NewsTradeDiscussionAI Drug Sector Mania Is Starting On FDA Announcement Of Replacing Animal Testing With AI-based models
r/wallstreetbets · Apr 14, 2025
SDGR is explicitly listed as part of the potential AI drug sector gains.
very_positive +1.00
DDNewsTradeAI Drug Sector Mania Is Starting On FDA Announcement Of Replacing Animal Testing With AI-based models
r/wallstreetbets · Apr 14, 2025
SDGR is mentioned in the context of a predicted strong performance.
positive +0.90
Page 1 of 2 (6 total)
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙